Guard Therapeutic’s Private Placement

Setterwalls advised Guard Therapeutics on the deal. Guard Therapeutics International AB (publ) secured a private placement in the form of a directed share issue of approximately...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

TrusTrace’s Financing Round

Setterwalls advised Swin Technologies AB (TrusTrace) on the deal. Swin Technologies AB (TrusTrace) raised USD 24 million in an investment round. The investment round was led by...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

SynAct Pharma’s Private Placement

Setterwalls assisted SynAct Pharma AB on the deal. SynAct has carried out a private placement of shares and warrants to an entity managed by Heights Capital...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Alligator Bioscience’s Rights Offering

Baker McKenzie advised the Joint Bookrunners on the deal. Setterwalls has advised Alligator Bioscience AB. Alligator Bioscience has completed an oversubscribed preferential rights issue of approximately...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here